DBV Technologies (DBVT) Current Leases (2019 - 2026)
DBV Technologies (DBVT) reported Current Leases of $1.0 million for Q1 2026, up 41.04% year-over-year from $709000.0 in Q1 2025, and down 9.09% quarter-over-quarter from $1.1 million in Q4 2025.
DBV Technologies (DBVT) Current Leases (2019 - 2026) Analysis & Trends
DBV Technologies (DBVT) has 8 years of Current Leases data on file, last reported at $1.0 million in Q1 2026.
- Current Leases for Q1 2026 came in at $1.0 million, up 41.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 million (up 41.04% YoY), and the FY2025 annual result was $1.1 million, up 68.2% from the prior year.
- Current Leases eased to $1.0 million in Q1 2026 per DBVT's latest filing, from $1.1 million in the prior quarter.
- Over five years, Current Leases peaked at $2.0 million in Q1 2022 and troughed at $232000.0 in Q1 2024.
- A 5-year average of $1.2 million and a median of $1.1 million in 2025 frame the typical range for Current Leases.
- The sharpest annual moves came in 2024 and 2025: Current Leases sank 87.94% in 2024, then surged 205.6% in 2025.
- A 5-year view of Current Leases shows it stood at $1.9 million in 2022, then sank by 39.6% to $1.1 million in 2023, then plunged by 42.83% to $654000.0 in 2024, then soared by 68.2% to $1.1 million in 2025, then slipped by 9.09% to $1.0 million in 2026.
- Business Quant data shows DBVT's Current Leases at $1.0 million in Q1 2026, $1.1 million in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 998,000.00 |
| Mar 31, 2025 | 709,000.00 |
| Dec 31, 2024 | 654,000.00 |
| Sep 30, 2024 | 374,000.00 |
| Jun 30, 2024 | 380,000.00 |
| Mar 31, 2024 | 232,000.00 |
| Dec 31, 2023 | 1.14 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Jun 30, 2023 | 1.94 Mn |
| Mar 31, 2023 | 1.92 Mn |
| Dec 31, 2022 | 1.89 Mn |
| Sep 30, 2022 | 1.38 Mn |
| Jun 30, 2022 | 1.97 Mn |
| Mar 31, 2022 | 2.03 Mn |
| Dec 31, 2021 | 3.00 Mn |
| Sep 30, 2021 | 2.66 Mn |
| Jun 30, 2021 | 2.76 Mn |